Back to results
US 2022/0031620 A1Published application
Lyophilisate of treosulfan
AssigneeMedac Gesellschaft FüR Klinische SpezialpräParate Mbh
InventorSebastian Bialleck
Life of this patent
Estimating the term…
Abstract
A lyophilisate of treosulfan is described which possesses favourable characteristics in terms of a short reconstitution time and a high purity and stability and which is particularly useful in the treatment of cancer and for conditioning therapy before transplantation of bone marrow or blood stem cells.
Claims24
Lyophilisate of treosulfan, wherein the lyophilisate comprises crystalline form B of treosulfan exhibiting an X-ray powder diffraction pattern having characteristic peaks at 20.87 and 23.47±0.20 degrees 2Θ.
(canceled)
Dependencies are inferred from the claim text.